Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged ≥60 Years: 3 Years of Follow-up in the CAPAMIS Study

Nav

General Info

Geography

Spain (ESP)

Time period covered

01/2008 - 12/2011

Data type

Scientific literature

Keywords

Pneumococcal pneumonia, Pneumococcal vaccines

Citation

Authors

Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, Hospital-Guardiola I

Journal

Clin Infect Dis

Volume

Issue

Pages

909–17

Publication year

2014

Suggested citation

Ochoa-Gondar O, Vila-Corcoles A, Rodriguez-Blanco T, Gomez-Bertomeu F, Figuerola-Massana E, Raga-Luria X, Hospital-Guardiola I. Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged ≥60 Years: 3 Years of Follow-up in the CAPAMIS Study. Clin Infect Dis. 2014; 58(7): 909–17.

GHDx Entry last modified on: Jan 12, 2022

Header sites

Search form

Main menu

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine Against Community-Acquired Pneumonia in the General Population Aged ≥60 Years: 3 Years of Follow-up in the CAPAMIS Study

Nav